Trinity Biotech Files Routine 6-K Report
Ticker: TRIB · Form: 6-K · Filed: May 16, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | May 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $6 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, compliance, foreign-private-issuer
TL;DR
Trinity Biotech filed a standard 6-K, no major news, just compliance.
AI Summary
Trinity Biotech plc filed a Form 6-K on May 16, 2024, to report its status as a foreign private issuer. The company, based in Dublin, Ireland, is involved in the in vitro and in vivo diagnostic substances industry. This filing is routine and does not contain specific financial or operational updates for the month of May 2024.
Why It Matters
This filing confirms Trinity Biotech's ongoing compliance with SEC reporting requirements for foreign private issuers, indicating business continuity.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material information that would typically impact risk.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- 0000888721 (company) — Central Index Key
- 2835 (company) — Standard Industrial Classification
- May 2024 (date) — Reporting Period
- 20240516 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report information required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 for the month of May 2024, specifically confirming its status as a foreign private issuer.
When was this Form 6-K filed?
This Form 6-K was filed on May 16, 2024.
Where is Trinity Biotech plc headquartered?
Trinity Biotech plc's principal executive office is located at IDA Business Park, Bray, Co. Wicklow, Ireland.
Does Trinity Biotech plc file annual reports under Form 20-F or 40-F?
Trinity Biotech plc indicates that it files annual reports under cover of Form 20-F.
What industry does Trinity Biotech plc operate in?
Trinity Biotech plc operates in the In Vitro & In Vivo Diagnostic Substances industry, classified under SIC code 2835.
Filing Stats: 308 words · 1 min read · ~1 pages · Grade level 14.4 · Accepted 2024-05-16 13:15:37
Key Financial Figures
- $6 million — ate for supply in 2024 to approximately $6 million. Additionally, the Company raised its g
Filing Documents
- zk2431479.htm (6-K) — 13KB
- exhibit_99-1.htm (EX-99.1) — 8KB
- image1.jpg (GRAPHIC) — 90KB
- 0001178913-24-001767.txt ( ) — 147KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/Des Fitzgerald Des Fitzgerald Interim Chief Financial Officer Date: May 16, 2024